The Impact of Antiangiogenic Therapy Combined With Transarterial Chemoembolization on Enhancement Based Quantitative Tumor Response Assessment in Patients With Hepatocellular Carcinoma

PURPOSE: To investigate whether Bevacizumab compromises early response assessment after Transarterial Chemoembolization (TACE) in patients with hepatocellular carcinoma by 3D quantitative European Association for the Study of the Liver (qEASL) criteria in comparison to other imaging-based criteria....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Imaging
Hauptverfasser: Smolka, Susanne, Chapiro, Julius, Manzano, Wilfred, Treilhard, John, Reiner, Eric, Deng, Yanhong, Zhao, Yan, Hamm, Bernd, Duncan, James S, Gebauer, Bernhard, Lin, MingDe, Geschwind, Jean-François
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5720941/
https://ncbi.nlm.nih.gov/pubmed/28668723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinimag.2017.05.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge